from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1197/esxK

LFCtreatmentdescriptionclass of inhibitor

0.046

Amikacinug/mL Amikacintranslation

0.174

Cap5-10ug/mL Capreomycintranslation

-0.676

Rox10-50 ug/mL Roxithromycintranslation

0.176

SM2-5 ug/mL Streptomycintranslation

-0.451

Tet5-10 ug/mL Tetracyclinetranslation

-0.918

Rif0.2-5ug/mL Rifampicintranscription

-0.820

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.012

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.431

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.507

CPZ10-50 ug/mL Chlorpromazinerespiration

0.283

Clofazimine10-13 ug/mL Clofaziminerespiration

0.279

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.328

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.013

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.098

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.235

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.723

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.401

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.365

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.205

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.355

KCN5-20 ug/mL Potassium cyaniderespiration

0.031

NaN30.2-2 mM Sodium aziderespiration

0.626

Nigericin50 uM Nigericinrespiration

-0.798

TRC10-150 ug/mL Triclosanrespiration

-0.004

TRZ10-25 ug/mL Thioridazinerespiration

-2.151

Valinomycin0.5-10 uM Valinomycinrespiration

0.270

ZnSO42 mM ZnSO4respiration

-0.483

menadione6-10 ug/mL Menadionerespiration

1.102

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.442

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.036

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.480

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.382

NRP_1Non-replicating persistence stage 1dosRassociated

0.816

Amp0.2mg/mL AmpicillincellWall

0.298

Cephalexin20-100 ug/mL CephalexincellWall

0.045

Cerulenin0.32-5 ug/mL CerulenincellWall

1.035

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.962

EMB10-20 ug/mL EthambutolcellWall

0.682

Eta12-40 ug/mL EthionamidecellWall

0.411

INH0.2-0.4 ug/mL IsoniazidcellWall

0.402

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.597

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.278

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.426

BZA0.12 mg/mL BenzamidearomaticAmides

-1.099

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-1.191

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.476

H2O24 mM hydrogen peroxideDNAdamaging

0.556

Levo10 ug/mL LevofloxacinDNAdamaging

0.322

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.907

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.505

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.414

UVUV-irradiationDNAdamaging

-0.798

ARP41-4 ug/mL Antitubercular compound ARP4?

0.881

Antimycin12.5-50 ug/mL Antimycin A?

0.257

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.535

PA_110-50 ug/mL Antitubercular compound PA-1?

0.746

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.863

PA8240.2-2 ug/mL PA-824?

0.011

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.203

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.261

Verapamil50 uM Verapamil?

0.259

mercaptoethanol2 mM 2-Mercaptoethanol?

0.277

methoxatin10-20 ug/mL Methoxatin?